Thoma Bravo to Acquire Accelerant in $4 Billion All-Cash Take-Private Deal
By Lauren Towner · 13 August 2026
In brief: Accelerant will be acquired by Thoma Bravo in an all-cash transaction valued at over $4 billion, providing shareholders with $20.25 per share and transitioning the risk exchange to private ownership by H1 2027.
| Enterprise Value | More than $4 billion |
|---|---|
| Price Per Share | $20.25 in cash |
| Share Price Premium | 49% |
| Expected Closing | First half of 2027 |

Quick Summary
Accelerant has entered a definitive agreement to be acquired by Thoma Bravo in an all-cash deal valued at over $4 billion. The Thoma Bravo acquisition offers shareholders $20.25 per share, a 49% premium, transitioning the data-driven risk exchange platform into a privately held company by 2027.
How Does the Thoma Bravo Acquisition Benefit Accelerant?
The Thoma Bravo acquisition provides Accelerant with the strategic financial resources and deep software sector expertise required to scale its proprietary risk exchange. By returning to private ownership, Accelerant aims to solidify its position as the primary infrastructure for the specialty insurance marketplace. Key benefits include:
- Access to Thoma Bravo’s $172 billion AUM ecosystem.
- Enhanced underwriting innovation through technology investment.
- Accelerated data-fueled platform development to support MGA growth.
What Are the Financial Terms for Accelerant Shareholders?
Under the agreement, stockholders will receive $20.25 per share in cash. This represents a significant 49% premium over the closing price on August 12, 2026. The deal carries an enterprise value exceeding $4 billion and includes a unique 6% ticking fee if regulatory delays occur. Altamont Capital Partners, holding 82% voting rights, has already committed to the deal, ensuring a smooth path to the expected H1 2027 closing.
How Does Accelerant Transform Specialty Insurance?
Accelerant solves the risk capital gap for underwriters by providing a data-driven risk exchange. This platform connects specialty underwriters directly with capital providers, utilizing real-time analytics to price risk more accurately. The Thoma Bravo acquisition will further invest in these transparent underwriting insights, allowing the platform to serve as the "rails" for the industry while maintaining low-volatility premium performance across market cycles.
FF NEWS TAKE:
This Thoma Bravo acquisition definitely moves the needle for the insurtech sector. By taking Accelerant private at a massive $4 billion valuation, Thoma Bravo is betting big on the digitization of specialty risk. This deal signals that the MGA market is no longer a niche corner of insurance but a tech-driven powerhouse. Expect Accelerant to aggressively outpace traditional competitors now that they are unburdened by quarterly public reporting.
Frequently asked questions
What is the total value of the Thoma Bravo acquisition of Accelerant?
The acquisition has an enterprise value of more than $4 billion. Under the definitive agreement, Accelerant Class A and Class B stockholders will receive $20.25 per share in cash, which represents a 49% premium over the company's closing share price on August 12, 2026.
When is the Accelerant take-private deal expected to close?
The transaction is currently expected to close in the first half of 2027. The closing is subject to customary conditions, including approval by Accelerant shareholders and the satisfaction of required insurance regulatory approvals.
Will Accelerant remain a public company after the deal?
No, upon completion of the transaction, Accelerant will become a privately held company. Its common shares will be delisted and will no longer be traded on the New York Stock Exchange (NYSE).
About the companies
Accelerant
Part of Altamont Capital Partners · Website · 8 stories on FF News since 2022
Previously on FF News:
Walkers
1 story on FF News since 2026
Companies in this story: Accelerant, Skadden, Arps, Slate, Meagher & Flom LLP, Walkers, Houlihan Lokey, Thoma Bravo, BMO Capital Markets, Morgan Stanley & Co. LLC, Goodwin Procter LLP, Conyers Dill & Pearman, Ropes & Gray LLP, Wells Fargo, Altamont Capital Partners, Sidley Austin LLP, Maples Group, Paul Hastings, New York Stock Exchange
People in this story: A.J. Rohde, Jeff Radke, Matt LoSardo, Karen Meriwether